STADA Arzneimittel AG, DE0007251803

STADA Arzneimittel AG, DE0007251803

10.07.2017 - 14:16:50

STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany 2. Reason for notification   Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:Signing of irrevocable undertaking agreement regarding the tendering of shares in a takeover offer 3. Details of person subject to the notification obligation Name: City and country of registered office: Cinven Capital Management (VI) General Partner Limited Saint Peter Port, GuernseyChannel Islands 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached: 07 Jul 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 0 % 19.60 % 19.60 % 62,342,440 Previous notification 0 % 13.36 % 13.36 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) % % Total % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % Irrevocable Undertaking Agreements 21.07.2017 n/a Physical 12221410 19.60 %       Total 12221410 19.60 % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Cinven Capital Management (VI) General Partner Limited % % % Cinven Capital Management (VI) Limited Partnership Incorporated % % % Sixth Cinven Fund (No. 1) Limited Partnership % % % Ciddan S.à r.l. % % % Nidda Topco S.à r.l. % % % Nidda Midco S.à r.l. % % % Nidda German Topco GmbH % % % Nidda German Midco GmbH % % % Nidda BondCo GmbH % % % Nidda Healthcare Holding AG % 19,60 % 19,60 %   Cinven Capital Management (VI) General Partner Limited % % % Cinven Capital Management (VI) Limited Partnership Incorporated % % % Sixth Cinven Fund (No. 2) Limited Partnership % % % Ciddan S.à r.l. % % % Nidda Topco S.à r.l. % % % Nidda Midco S.à r.l. % % % Nidda German Topco GmbH % % % Nidda German Midco GmbH % % % Nidda BondCo GmbH % % % Nidda Healthcare Holding AG % 19,60 % 19,60 %   Cinven Capital Management (VI) General Partner Limited % % % Cinven Capital Management (VI) Limited Partnership Incorporated % % % Sixth Cinven Fund (No. 3) Limited Partnership % % % Ciddan S.à r.l. % % % Nidda Topco S.à r.l. % % % Nidda Midco S.à r.l. % % % Nidda German Topco GmbH % % % Nidda German Midco GmbH % % % Nidda BondCo GmbH % % % Nidda Healthcare Holding AG % 19,60 % 19,60 %   Cinven Capital Management (VI) General Partner Limited % % % Cinven Capital Management (VI) Limited Partnership Incorporated % % % Sixth Cinven Fund (No. 4) Limited Partnership % % % Ciddan S.à r.l. % % % Nidda Topco S.à r.l. % % % Nidda Midco S.à r.l. % % % Nidda German Topco GmbH % % % Nidda German Midco GmbH % % % Nidda BondCo GmbH % % % Nidda Healthcare Holding AG % 19,60 % 19,60 % 9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

10.07.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel

Germany Internet: www.stada.de   End of News DGAP News Service

591125  10.07.2017 

@ dgap.de